Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms

Thrombosis and Haemostasis

Volumn 85, Issue 5, 2001, Pages 810-820

  Joop, K ^a   Berckmans, R J ^a   Nieuwland, R ^a   Berkhout, J ^a   Romijn, F P H T M ^a   Hack, C E ^a   Sturk, A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coagulation; Factor XI; Factor XII; Microparticles; Sepsis; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; C REACTIVE PROTEIN; ELASTASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEPSIS; STAINING; THROMBIN TIME; THROMBOCYTE;

EID: 0035002186     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615753     Document Type: Article

References (45)

1. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface and are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity
2. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
3. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: A flow cytometric study
4. Platelet-derived microparticles express high affinity receptors for factor VIII
5. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide
6. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells
7. The isolation and characterization of 60 nm vesicles ("nanovesicles") produced during ionophore A23187-induced budding of human erythrocytes
8. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes
9. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus
10. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects and observations in patients during adult respiratory distress sydnrome and cardiac surgery
11. Platelet microparticles and calcium homeostasis in acute coronary ischemias
12. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia
13. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias
14. Significance of platelet-derived microparticles in uremia
15. Platelet microparticles in ITP
16. Clinical significance of platelet-derived microvesicles: Demonstration of their presence in patients suffering from disseminated intravascular coagulation (DIC)
17. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
18. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant
19. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation
20. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
21. The sepsis syndrome
22. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII
23. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin
24. Platelet-derived microparticles associate with fibrin during thrombosis
25. Tissue factor: Then and now
26. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons
27. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
28. Thromboembolism and bleeding tendency in congenital factor XII deficiency: A study on 74 subjects from 14 Swiss families
29. Factor XII clotting activity and antigen levels in patients with thromboembolic disease
30. Interactions of neutrophils and coagulation proteins
31. Assembly of contact-phase factors on the surface of the human neutrophil membrane
32. Factor XI deficiency
33. Facor XI activation in a revised model of blood coagulation
34. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis
35. Thrombin activates factor XI on activated platelets in the absence of factor XII
36. Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene
37. Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression
38. Disseminated intravascular coagulation
39. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets
40. Microparticle deposition in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: Quantitation and localization by confocal scanning laser microcopy
41. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques
42. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators
43. Factor XI activation by meizothrombin: Stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine
44. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway
45. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway